Arspharmaceuticalsoperationsinc The Vice President, Head of Clinical Development – Allergy & Urticaria leads clinical strategy and execution for ARS Pharma’s allergy and urticaria portfolio, overseeing clinical trial design from early-phase proof-of-concept through global registration. This role serves as the senior authority on the allergy/urticaria therapeutic area and regulatory landscape, partnering cross-functionally to build integrated development plans.